HomeNewsBusinessAnnouncementsZydus receives final approval from USFDA for Aspirin and Dipyridamole capsules

Zydus receives final approval from USFDA for Aspirin and Dipyridamole capsules

Zydus Cadila has received the final approval from the USFDA to market Aspirin & extended-release Dipyridamole capsules in the strengths of 25 mg/200 mg.

August 30, 2017 / 11:01 IST

Story continues below Advertisement

Zydus receives final approval from the USFDA for Aspirin and Extended-Release Dipyridamole CapsulesSource : BSE

first published: Aug 30, 2017 11:01 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Zydus receives final approval from USFDA for Aspirin and Dipyridamole capsules

Zydus Cadila has received the final approval from the USFDA to market Aspirin & extended-release Dipyridamole capsules in the strengths of 25 mg/200 mg.

News

Features

Tools

Specials

Network 18 Sites

Personal Finance

Quick Links